• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低收入和中等收入国家慢性肾脏病患者心血管疾病的患病率、发病率及相关死亡率:一项系统评价与荟萃分析方案

Prevalence, incidence and associated mortality of cardiovascular disease in patients with chronic kidney disease in low- and middle-income countries: a protocol for a systematic review and meta-analysis.

作者信息

Temgoua Mazou N, Danwang Celestin, Agbor Valirie Ndip, Noubiap Jean Jacques

机构信息

Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

Department of Surgery and Specialties, Faculty of Medicine and Biomedical Sciences,University of Yaoundé I, Yaoundé, Cameroon.

出版信息

BMJ Open. 2017 Aug 28;7(8):e016412. doi: 10.1136/bmjopen-2017-016412.

DOI:10.1136/bmjopen-2017-016412
PMID:28851783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5629708/
Abstract

INTRODUCTION

Chronic kidney disease (CKD) is a global public health problem, with cardiovascular disease (CVD) being the major cause of mortality in these patients. Despite a high burden of CKD among patients in low/middle-income countries (LMICs), evidence on the distribution of CVD among these patients is lacking. This review seeks to determine the prevalence, incidence and mortality risks of CVD in patients with CKD in LMICs.

METHODS AND ANALYSIS

A systematic search of Medline, Scopus, Embase, Cumulative Index of Nursing and Allied Health and WHO Global Health Library databases for published studies reporting on the prevalence, incidence and associated mortality risk of CVD in CKD patients in LMICs will be conducted from 1 May 1987 to 1 July 2017 with no language restriction. Two authors will independently screen, select studies, extract data and assess the risk of bias in each study. Clinically homogeneous studies will be pooled after assessing for clinical and statistical heterogeneity using the χ test on Cochrane's Q statistic which is quantified by I values; assuming that I values of 25%, 50% and 75% represent low, medium and high heterogeneity, respectively. Funnel-plot analysis and Egger's test will be used to detect publication bias. Results will be presented according to WHO Regions (Africa, Americas, Eastern Mediterranean, Europe, South-East Asia and Western Pacific).

ETHICS AND DISSEMINATION

This proposed study will not require ethical approval as it will be based on published data. We will publish the final report of this review in a peer-reviewed journal, and the findings will be disseminated to the appropriate health authorities.

摘要

引言

慢性肾脏病(CKD)是一个全球性的公共卫生问题,心血管疾病(CVD)是这些患者死亡的主要原因。尽管中低收入国家(LMICs)的患者中CKD负担沉重,但缺乏关于这些患者中CVD分布情况的证据。本综述旨在确定LMICs中CKD患者CVD的患病率、发病率和死亡风险。

方法与分析

将对Medline、Scopus、Embase、护理及相关健康累积索引和世界卫生组织全球健康图书馆数据库进行系统检索,以查找1987年5月1日至2017年7月1日期间发表的关于LMICs中CKD患者CVD患病率、发病率及相关死亡风险的研究,无语言限制。两名作者将独立筛选、选择研究、提取数据并评估每项研究的偏倚风险。在使用Cochrane Q统计量的χ检验评估临床和统计异质性后,将对临床同质的研究进行合并,该统计量由I值量化;假设I值为25%、50%和75%分别代表低、中、高异质性。将使用漏斗图分析和Egger检验来检测发表偏倚。结果将根据世界卫生组织区域(非洲、美洲、东地中海、欧洲、东南亚和西太平洋)呈现。

伦理与传播

本拟议研究无需伦理批准,因为它将基于已发表的数据。我们将在同行评审期刊上发表本综述的最终报告,并将研究结果传播给适当的卫生当局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/5629708/cd145bb866be/bmjopen-2017-016412f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/5629708/cd145bb866be/bmjopen-2017-016412f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d78/5629708/cd145bb866be/bmjopen-2017-016412f01.jpg

相似文献

1
Prevalence, incidence and associated mortality of cardiovascular disease in patients with chronic kidney disease in low- and middle-income countries: a protocol for a systematic review and meta-analysis.低收入和中等收入国家慢性肾脏病患者心血管疾病的患病率、发病率及相关死亡率:一项系统评价与荟萃分析方案
BMJ Open. 2017 Aug 28;7(8):e016412. doi: 10.1136/bmjopen-2017-016412.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Incidence of major complications after percutaneous native renal biopsies in adults from low-income to middle-income countries: a protocol for systematic review and meta-analysis.低收入至中等收入国家成年人经皮肾穿刺活检术后主要并发症的发生率:系统评价与荟萃分析方案
BMJ Open. 2018 Apr 27;8(4):e020891. doi: 10.1136/bmjopen-2017-020891.
4
Epidemiology of heart failure in pediatric populations in low- and middle-income countries: a protocol for a systematic review.中低收入国家儿科人群心力衰竭的流行病学:系统评价方案。
Syst Rev. 2018 Apr 2;7(1):52. doi: 10.1186/s13643-018-0717-6.
5
Prevalence of unrecognized or "silent" myocardial ischemia in chronic kidney disease patients: Protocol for a systematic review and meta-analysis.慢性肾脏病患者无症状或“沉默性”心肌缺血的患病率:系统评价和荟萃分析方案。
PLoS One. 2021 Sep 2;16(9):e0256934. doi: 10.1371/journal.pone.0256934. eCollection 2021.
6
Global prevalence of spondyloarthritis in low-income and middle-income countries: a systematic review and meta-analysis protocol.低收入和中等收入国家脊柱关节炎的全球患病率:一项系统评价和荟萃分析方案
BMJ Open. 2020 Oct 29;10(10):e041180. doi: 10.1136/bmjopen-2020-041180.
7
Prevalence and patterns of congenital heart diseases in Africa: a systematic review and meta-analysis protocol.非洲先天性心脏病的患病率及模式:一项系统评价和荟萃分析方案
BMJ Open. 2017 Feb 14;7(2):e015633. doi: 10.1136/bmjopen-2016-015633.
8
Global epidemiology of acute generalised peritonitis: a protocol for a systematic review and meta-analysis.全球急性弥漫性腹膜炎的流行病学:一项系统评价和荟萃分析的方案。
BMJ Open. 2020 Jan 8;10(1):e034326. doi: 10.1136/bmjopen-2019-034326.
9
Prevalence and incidence of hypertension in the global HIV-infected population: a systematic review and meta-analysis protocol.全球艾滋病毒感染人群中高血压的患病率和发病率:一项系统评价和荟萃分析方案
BMJ Open. 2017 Oct 12;7(10):e016531. doi: 10.1136/bmjopen-2017-016531.
10
Burden, risk factors and outcomes of hyperemesis gravidarum in low-income and middle-income countries (LMICs): systematic review and meta-analysis protocol.中低收入国家(LMICs)中妊娠剧吐的负担、风险因素和结局:系统评价和荟萃分析方案。
BMJ Open. 2019 Apr 4;9(4):e025841. doi: 10.1136/bmjopen-2018-025841.

引用本文的文献

1
Hemoglobin Glycation Index: A Novel Risk Factor for Incident Chronic Kidney Disease in an Apparently Healthy Population.血红蛋白糖化指数:健康人群中新发慢性肾脏病的一个风险因素。
J Clin Endocrinol Metab. 2024 Feb 20;109(3):e1055-e1060. doi: 10.1210/clinem/dgad638.
2
The prevalence and influencing factors of frailty in patients with chronic kidney disease: a systematic review and meta-analysis.慢性肾脏病患者衰弱的患病率及影响因素:系统评价和荟萃分析。
Int Urol Nephrol. 2024 Feb;56(2):767-779. doi: 10.1007/s11255-023-03739-2. Epub 2023 Aug 14.
3
Multidisciplinary treatment for patients with chronic kidney disease in pre-dialysis minimizes costs: a four-year retrospective cohort analysis.

本文引用的文献

1
Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.全球慢性肾脏病患病率——一项系统评价与荟萃分析
PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. eCollection 2016.
2
Chronic kidney disease in low- and middle-income countries.低收入和中等收入国家的慢性肾脏病
Nephrol Dial Transplant. 2016 Jun;31(6):868-74. doi: 10.1093/ndt/gfv466. Epub 2016 Feb 4.
3
Factors Affecting the Referral Time to Nephrologists in Patients With Chronic Kidney Disease: A Prospective Cohort Study in Korea.
多学科治疗可使透析前慢性肾脏病患者的成本最小化:一项四年回顾性队列分析。
J Bras Nefrol. 2021 Jul-Sep;43(3):330-339. doi: 10.1590/2175-8239-JBN-2020-0226.
4
Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease.尿毒症溶质作为慢性肾脏病相关心血管疾病的治疗靶点。
Nat Rev Nephrol. 2021 Jun;17(6):402-416. doi: 10.1038/s41581-021-00408-4. Epub 2021 Mar 23.
5
Molecular Mechanisms Underlying the Cardiovascular Toxicity of Specific Uremic Solutes.特定尿毒症溶质导致心血管毒性的分子机制。
Cells. 2020 Sep 2;9(9):2024. doi: 10.3390/cells9092024.
6
The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease.高密度脂蛋白在慢性肾脏病患者中的作用和功能及心血管疾病风险。
Int J Mol Sci. 2020 Jan 17;21(2):601. doi: 10.3390/ijms21020601.
7
The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular Disease.胰岛素抵抗和慢性肾脏病对炎症及心血管疾病的影响
Clin Med Insights Endocrinol Diabetes. 2018 Aug 1;11:1179551418792257. doi: 10.1177/1179551418792257. eCollection 2018.
影响慢性肾脏病患者转诊至肾科医生时间的因素:韩国一项前瞻性队列研究
Medicine (Baltimore). 2016 May;95(19):e3648. doi: 10.1097/MD.0000000000003648.
4
Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.世界六个地区的慢性肾脏病和心血管风险(ISN-KDDC):一项横断面研究。
Lancet Glob Health. 2016 May;4(5):e307-19. doi: 10.1016/S2214-109X(16)00071-1.
5
An accurate test for homogeneity of odds ratios based on Cochran's Q-statistic.一种基于 Cochr an Q 统计量的精确的比值比同质性检验。
BMC Med Res Methodol. 2015 Jun 10;15:49. doi: 10.1186/s12874-015-0034-x.
6
Addressing the global burden of chronic kidney disease through clinical and translational research.通过临床和转化研究应对慢性肾脏病的全球负担。
Trans Am Clin Climatol Assoc. 2014;125:229-43; discussion 243-6.
7
The link between chronic kidney disease and cardiovascular disease.慢性肾病与心血管疾病之间的联系。
J Nephropathol. 2014 Jul;3(3):99-104. doi: 10.12860/jnp.2014.19. Epub 2014 Jul 1.
8
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.慢性肾脏病与心血管风险:流行病学、发病机制与预防。
Lancet. 2013 Jul 27;382(9889):339-52. doi: 10.1016/S0140-6736(13)60595-4. Epub 2013 May 31.
9
Interrater reliability: the kappa statistic.组内一致性:kappa 统计量。
Biochem Med (Zagreb). 2012;22(3):276-82.
10
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement.评估患病率研究中的偏倚风险:现有工具的修改和评价者间一致性的证据。
J Clin Epidemiol. 2012 Sep;65(9):934-9. doi: 10.1016/j.jclinepi.2011.11.014. Epub 2012 Jun 27.